ICD-9-CM Volume 2 Index entries containing back-references to
655.5:
- Absorption
chemical NEC 989.9

specified chemical or substance - see Table of Drugs and Chemicals
through placenta or breast milk (fetus or newborn) 760.70
drug NEC (see also Reaction, drug)
through placenta or breast milk (fetus or newborn) 760.70
- Dependence
drug NEC 304.9

analgesic NEC 304.6

combination (excluding morphine or opioid type drug) NEC 304.8


morphine or opioid type drug with any other drug 304.7

complicating pregnancy, childbirth, or puerperium 648.3


affecting fetus or newborn 779.5

hallucinogenic 304.5

hypnotic NEC 304.1

narcotic NEC 304.9

psychostimulant NEC 304.4

sedative 304.1

soporific NEC 304.1

specified type NEC 304.6

suspected damage to fetus affecting management of pregnancy 655.5
synthetic, with morphine-like effect 304.0

tranquilizing 304.1
- Intoxication
chemical - see also Table of Drugs and Chemicals
via placenta or breast milk 760.70
drug 292.89

with delirium 292.81

correct substance properly administered (see also Allergy, drug) 995.27

newborn 779.4

obstetric anesthetic or sedation 668.9


affecting fetus or newborn 763.5

overdose or wrong substance given or taken - see Table of Drugs and Chemicals
pathologic 292.2

specific to newborn 779.4

via placenta or breast milk 760.70
fetus or newborn, via placenta or breast milk 760.70
- Noxious
substances transmitted through placenta or breast milk (affecting fetus or newborn) 760.70
- Pregnancy (single) (uterine) (without sickness) V22.2

management affected by
abnormal, abnormality
advanced maternal age NEC 659.6

antibodies (maternal)
appendicitis 648.9

bariatric surgery status 649.2

coagulation defect 649.3

elderly multigravida 659.6

elderly primigravida 659.5

epilepsy 649.4

fetal (suspected)

abnormality 655.9


acidemia 656.3


anencephaly 655.0


bradycardia 659.7


central nervous system malformation 655.0


chromosomal abnormalities (conditions classifiable to 758.0
-758.9
) 655.1


damage from


drugs 655.5



obstetric, anesthetic, or sedative 655.5



environmental toxins 655.8



intrauterine contraceptive device 655.8



maternal


radiation 655.6


death (near term) 656.4



early (before 22 completed weeks gestation) 632


distress 656.8


excessive growth 656.6


growth retardation 656.5


hereditary disease 655.2


hydrocephalus 655.0


intrauterine death 656.4


poor growth 656.5


spina bifida (with myelomeningocele) 655.0

fetal-maternal hemorrhage 656.0

gastric banding status 649.2

gastric bypass status for obesity 649.2

hereditary disease in family (possibly) affecting fetus 655.2

incompatibility, blood groups (ABO) 656.2

insufficient prenatal care V23.7

intrauterine death 656.4

isoimmunization (ABO) 656.2

large-for-dates fetus 656.6

light-for-dates fetus 656.5

meconium in liquor 656.8

mental disorder (conditions classifiable to 290
-303
, 305.0
, 305.2
-305.9
, 306
-316
, 317
-319
) 648.4

multiparity (grand) 659.4

obesity 649.1

poor obstetric history V23.49

postmaturity
post-term pregnancy 645.1

previous
prolonged pregnancy 645.2

small-for-dates fetus 656.5

smoking 649.0

spotting 649.5

tobacco use disorder 649.0

young maternal age 659.8
- Transmission of chemical substances through the placenta (affecting fetus or newborn) 760.70

suspected, affecting management of pregnancy 655.5